About Us

EVDL is a Hong Kong homegrown start-up formed by medical doctors, experienced scientists and engineers having the vision and passion in providing solutions to unmet medical needs. With a unique integration of expertise of our multidisciplinary professionals, from scientific research to manufacturing, we are able to transfer knowledge to innovative yet practical diagnostic solutions to the community. As part of the Avalon Biomedical (Management) Limited, a local biotechnology incubator, we aspire to become a worldwide leader in diagnostic industry and to push Diagnosis beyond Boundaries!

EVDL is a Hong Kong homegrown start-up formed by medical doctors, experienced scientists and engineers having the vision and passion in providing solutions to unmet medical needs. With a unique integration of expertise of our multidisciplinary professionals, from scientific research to manufacturing, we are able to transfer knowledge to innovative yet practical diagnostic solutions to the community. As part of the Avalon Biomedical (Management) Limited, a local biotechnology incubator, we aspire to become a worldwide leader in diagnostic industry and to push Diagnosis beyond Boundaries!

Milestone

2015

Project Start &
Design Phase

July

Emerging Viral Diagnostics (HK) Limited (“EVDL”) was founded

The core research team is formed by famous scientists, doctors, experienced biotechnologists and engineers as well as technical and technology investors.

Nov

Establishment of Respiratory Virus Research Foundation

HKU and PolyU jointly announced the establishment of “Respiratory Virus Research Foundation”. EVDL and the research team from the Universities immediately kickstarted related virus and translational research work.

2018

Establishment of Prototype Machine &
Biochemistry Reagents

Dec

Successfully Detected Samples

Successful detection of clinical samples in Queen Mary Hospital (QMH). Design of prototype machine and biochemistry reagents established and with more optimization work in the pipeline.

2020

First Introduction of the EVDL System to the Public

JAN

Demonstrated the strength as Platform Technology during outbreak of COVID-19

The research team promptly adapted the system and successfully detected SARS-CoV-2 clinical samples during the outbreak of COVID-19 in late 2019. Followed by a Press Conference held in PolyU announcing the technology to public in February.

2021

Technology Transfer from University Scale to Industrial Scale

Jan

First Production Plant in PingShan, Shenzhen

Under a collaboration framework agreement with the People’s Government of Pingshan District, Shenzhen, Guangdong Province, China and Xiangxue Pharmaceutical, a factory plant is established in PingShan, Shenzhen.

JUL

First Production Plant in Hong Kong

EVDL celebrates its first production plant with a focus on the device. This site will also act as engineering workshop and main hub for device's R&D work.

2022

A Leap Forward to Further Expansion and Certification

JUN

Device Production Plant in Hong Kong is ISO 13485:2016 Certified

Proud to announce the site is ISO 13485:2016 certified and in compliance with international quality management standard for medical device.

AUG

Signing Ceremony of Strategic Partnership and Opening Ceremony of Production Site in MARS Centre, Hong Kong

EVDL enters into strategic partnership with Shenzhou Space Biotechnology Group (“SBG”) and takes a step forward to clinical trials and product registration. The Company also celebrates the opening of its reagent and microfluidic cartridge production site

Milestone

2015

Project Start &
Design Phase

July

Emerging Viral Diagnostics (HK) Limited (“EVDL”) was founded

The core research team is formed by famous scientists, doctors, experienced biotechnologists and engineers as well as technical and technology investors.

Nov

Establishment of Respiratory Virus Research Foundation

HKU and PolyU jointly announced the establishment of “Respiratory Virus Research Foundation”. EVDL and the research team from the Universities immediately kickstarted related virus and translational research work.

2018

Establishment of Prototype Machine &
Biochemistry Reagents

Dec

Successfully Detected Samples

Successful detection of clinical samples in Queen Mary Hospital (QMH). Design of prototype machine and biochemistry reagents established and with more optimization work in the pipeline.

2020

First Introduction of the EVDL System to the Public

JAN

Demonstrated the strength as Platform Technology during outbreak of COVID-19

The research team promptly adapted the system and successfully detected SARS-CoV-2 clinical samples during the outbreak of COVID-19 in late 2019. Followed by a Press Conference held in PolyU announcing the technology to public in February.

2021

Technology Transfer from University Scale to Industrial Scale

Jan

First Production Plant in PingShan, Shenzhen

Under a collaboration framework agreement with the People’s Government of Pingshan District, Shenzhen, Guangdong Province, China and Xiangxue Pharmaceutical, a factory plant is established in PingShan, Shenzhen.

JUL

First Production Plant in Hong Kong

EVDL celebrates its first production plant with a focus on the device. This site will also act as engineering workshop and main hub for device's R&D work.

2022

A Leap Forward to Further Expansion and Certification

JUN

Device Production Plant in Hong Kong is ISO 13485:2016 Certified

Proud to announce the site is ISO 13485:2016 certified and in compliance with international quality management standard for medical device.

AUG

Signing Ceremony of Strategic Partnership and Opening Ceremony of Production Site in MARS Centre, Hong Kong

EVDL enters into strategic partnership with Shenzhou Space Biotechnology Group (“SBG”) and takes a step forward to clinical trials and product registration. The Company also celebrates the opening of its reagent and microfluidic cartridge production site

Our Manufacturing Sites

PingShan, China
PingShan, China

Under the co-operation framework agreement between the People’s Government of Pingshan District, Shenzhen, Guangdong Province, China and EVDL’s mother company Avalon BioMedical (Management) Limited, Phase 1 of this site was established in early 2021.

Manufacturing site for Cartridge production, including R&D Laboratory and Cleanroom
Tai Po, Hong Kong
Tai Po, Hong Kong

With the support from Hong Kong Science & Technology Parks Corporation (HKSTP), a manufacturing site including certified ISO-8 cleanroom located in MARS Centre has been established in 2022 for cartridge production.

Manufacturing site for Cartridge production, including R&D Laboratory and Cleanroom
Kwun Tong, Hong Kong
Kwun Tong, Hong Kong

EVDL’s R&D headquarters and is also the base of all Engineering work. Established in mid 2021 and is ISO13485:2016 (Medical Devices — Quality Management Systems) certified for device production.

Manufacturing site for Device production, also as R&D Headquarters and Engineering Workshop